- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03084120
Effect of the Maternal Obesity and/or the By-pass on the Growth and the Nutritional Balance of the Child (SMOOTHIE)
Study Overview
Status
Conditions
Intervention / Treatment
- Other: Collection of bloods samples for the mother
- Other: Retrieval of umbilical cord blood.
- Other: Retrieval of placenta.
- Other: Collection of newborn's and mother's lock of hair.
- Other: Dietetic Patient Outcomes Questionnaires for the mother.
- Other: Parental questionnaires : ASQ (Ages & Stages questionnaires) and CFQ (Child Feeding Questionnaire).
Detailed Description
The obesity represents a major problem of public health, not only in terms of inferred morbi-mortality but also in terms of economic responsibility. More than 50 % of the women old enough to procreate and 25 % of the women pregnant in Europe are in overweights or obese women. This rate does not stop increasing with prevalence which doubled in 30 years. The overweight or the maternal obesity expose the mother and the child to a greater risk of morbi-mortality. The nutritional stress to which is exposed the foetus during the pregnancy can even have long-term effects with a risk increased by overweight or obesity at the grown-up age, so participating in the cycle of the obesity (" Developmental Origins of Behaviour, Health, and Disease " (DOBHaD) concept).
The morbid obesity (IMC > 40 kg / m2) concern 1 to 3 % of the pregnant women. The gastric bypass surgery is envisaged in case of morbid obesity when the other treatments failed, with better results on the loss of weight and on the comorbidity associated with the obesity, in comparison with not surgical interventions. Near half of the patients who resort to the gastric bypass surgery are women old enough to procreate. Recent studies however moderated the beneficial effects of such an intervention with in particular a greater risk of intra-uterine delay of growth and possible nutritional deficiencies on the descent. The neonatal evaluation was limited to the clinical evaluation, and no biological evaluation of the vitamin and nutritional deficiencies on the growth of the foetus and the placenta was brought reported.
The placenta regulates the contribution in nutriments and oxygen and participle in the foetal homéostasie. The reactive placentary adaptations to an environment of surnutrition or the undernutrition can pull modifications of setting-up, development, functions of the placenta with genic modifications and épigénétiques. All these modifications intervene in a "critical window" in terms of development and participate in the phenomena of foetal programming.
Our working hypothesis is that the nutritional stress in utero associated with the maternal obesity and/or with the by-pass has a medium and long-term short-term, metabolic and neurodevelopmental nutritional impact on the descent.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Angers, France
- Recruiting
- UHAngers
-
Contact:
- Geraldine GASCOIN, Pr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
For "Gastric Bypass Surgery" arm :
- Pregnant women having undergone a Gastric bypass surgery before the pregnancy.
For "Reference group" arm :
- Pregnant women having a body mass index < 25 kg/m2 at the early pregnancy.
For "Overweight" arm :
- Pregnant women having a body mass index 25-30 kg/m2 at the early pregnancy.
For "Obesity " arm :
- Pregnant women having a body mass index > 30 kg/m2 at the early pregnancy.
Exclusion Criteria:
For every arms :
- Underage women
- Woman with a multiple pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Gastric bypass surgery
Pregnant women having undergone a Gastric bypass surgery before the pregnancy.
|
-During pregnancy, childbirth and after delivery
-During childbirth
-During childbirth
-During childbirth
-During pregnancy and after delivery
-At 2 years of age
|
|
Other: Reference group
Pregnant women having a body mass index <25 kg/m2 at the early pregnancy.
|
-During pregnancy, childbirth and after delivery
-During childbirth
-During childbirth
-During childbirth
-During pregnancy and after delivery
-At 2 years of age
|
|
Other: Overweight
Pregnant women having a body mass index 25-30 kg/m2 at the early pregnancy.
|
-During pregnancy, childbirth and after delivery
-During childbirth
-During childbirth
-During childbirth
-During pregnancy and after delivery
-At 2 years of age
|
|
Other: Obesity
Pregnant women having a body mass index > 30 kg/m2 at the early pregnancy.
|
-During pregnancy, childbirth and after delivery
-During childbirth
-During childbirth
-During childbirth
-During pregnancy and after delivery
-At 2 years of age
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Born measurement (weight) expressed in z-score.
Time Frame: At the childbirth
|
Z-scores are "pure numbers" (have no units of measurement attached to them).
|
At the childbirth
|
|
Born measurement (height) expressed in z-score.
Time Frame: At the childbirth
|
Z-scores are "pure numbers" (have no units of measurement attached to them).
|
At the childbirth
|
|
Born measurement (cranial perimeter) expressed in z-score.
Time Frame: At the childbirth.
|
Z-scores are "pure numbers" (have no units of measurement attached to them).
|
At the childbirth.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modification of auxological data (weight) at the age of 2.
Time Frame: At the age of 2.
|
Weight expressed in kilograms.
|
At the age of 2.
|
|
Modification of auxological data (height) at the age of 2.
Time Frame: At the age of 2.
|
Height expressed in centimeters.
|
At the age of 2.
|
|
Modification of auxological data (cranial perimeter) at the age of 2.
Time Frame: At the age of 2.
|
Cranial perimeter expressed in centimeters.
|
At the age of 2.
|
|
Modification of auxological data (BMI (Body Mass Index)) at the age of 2.
Time Frame: At the age of 2.
|
BMI (Body Mass Index) expressed in kg/m².
|
At the age of 2.
|
|
Modification of auxological data (speed of growth expressed) at the age of 2.
Time Frame: At the age of 2.
|
Speed of growth expressed in centimeters per year.
|
At the age of 2.
|
|
Neurodevelopmental modifications at the age of 2.
Time Frame: At the age of 2.
|
Parental questionnaire : Ages & Stages Questionnaires (ASQ).
|
At the age of 2.
|
|
Modifications of eating habits at the age of 2.
Time Frame: At the age of 2.
|
Parental questionnaire : Child Feeding Questionnaire (CFQ).
|
At the age of 2.
|
|
Vitamin dosages and micronutrients in the blood of cordon.
Time Frame: At the childbirth.
|
Dosages.
|
At the childbirth.
|
|
Vitamin dosages and maternal micronutrients in the first, second, third quarter of the pregnancy, at the childbirth and in 2 months after delivery.
Time Frame: First, second, third quarter of the pregnancy, at the childbirth and in 2 months after delivery.
|
Dosages.
|
First, second, third quarter of the pregnancy, at the childbirth and in 2 months after delivery.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Geraldine GASCOIN, Pr, University Hospital, Angers
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-A01546-45
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maternal Obesity
-
Sheffield Hallam UniversityCompletedMaternal Obesity Complicating Pregnancy | Maternal Obesity Complicating Childbirth
-
University of WyomingCompletedMaternal Obesity SyndromeUnited States
-
Arkansas Children's Hospital Research InstituteCompletedInflammation | Insulin Resistance | Childhood Obesity | Maternal Obesity During ChildbirthUnited States
-
Linkoeping UniversityCompletedMaternal Obesity During Childbirth | Labor; Arrested Active PhaseSweden
-
University of Modena and Reggio EmiliaUnknownExercise Addiction | Maternal Obesity Complicating Pregnancy | High-Risk Pregnancy | Inflammatory Status During Preganancy | Maternal Body CompositionItaly
-
University Hospital, ToulouseTerminated
-
Haseki Training and Research HospitalCompleted
-
University of ChileUnknown
-
University of IdahoRecruitingMaternal Behavior | Infant Development | Maternal Obesity | Breast Milk CollectionUnited States
-
Minia UniversityCompletedObesity During Pregnancy in Clinical PracticeEgypt
Clinical Trials on Collection of bloods samples for the mother
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruiting
-
Centre Hospitalier Universitaire, AmiensCompletedPollution; Exposure | Newborn | Microbiota | Breast Milk | Meconium | Pesticide | StoolFrance
-
European Organisation for Research and Treatment...TerminatedBreast CancerBelgium, Netherlands
-
Assistance Publique - Hôpitaux de ParisRecruitingChronic Hepatitis B Virus (HBV) InfectionFrance
-
Stanford UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitationLymphoma | Hematologic Diseases | LeukemiaUnited States
-
University Hospital, BordeauxActive, not recruiting
-
Centre Hospitalier Universitaire de NiceActive, not recruitingUrinary Tract InfectionsFrance
-
Ela ShaiCompletedInherited Platelet DisordersIsrael
-
Centre Hospitalier Universitaire DijonRecruiting
-
First Affiliated Hospital of Harbin Medical UniversityUnknown